# CardioVerse AI - Machine Learning Pipeline Summary

## Project Overview

This document summarizes the development of a clinical screening model for coronary artery disease prediction using the UCI Heart Disease dataset.

## Development Phases Completed

### Phase 1: Dataset Verification ✅
- Inspected original and processed datasets
- Verified file integrity and record counts
- Identified missing data patterns
- Validated feature encodings
- Assessed data leakage risks

### Phase 2: Clinical Screening Model Development ✅

#### Feature Set
**Clinical Screening Features (7 features):**
- age (years)
- sex (0=female, 1=male)
- cp (chest pain type 1-4)
- trestbps (resting blood pressure)
- chol (serum cholesterol)
- fbs (fasting blood sugar >120)
- restecg (resting ECG result)

**Excluded Diagnostic Features:**
- ca (number of vessels) - requires catheterization
- thal (thallium scan) - requires nuclear testing
- thalach, exang, oldpeak, slope - require exercise testing

#### Pipeline Architecture

**Data Processing:**
1. Missing Value Imputation (median strategy)
2. Feature Scaling (StandardScaler)
3. Train/Test Split (70/30 stratified)
4. Cross-Validation (5-fold stratified)

**Models Implemented:**
1. Logistic Regression (interpretable baseline)
2. Random Forest (ensemble method)
3. Dummy Classifier (baseline)

**Evaluation Metrics:**
- ROC-AUC (primary)
- PR-AUC
- Sensitivity/Specificity
- Brier Score (calibration)
- Accuracy

## Key Findings

### Dataset Quality
- **Cleveland**: 303 patients, balanced, minimal missing data
- **Hungarian**: 294 patients, extensive missing data in diagnostic features
- **Switzerland**: 123 patients, severe class imbalance (94% disease)
- **VA**: 200 patients, missing data in diagnostic features

### Model Selection Rationale
- Use Cleveland as primary development cohort
- External validation on Hungarian and VA (screening features only)
- Avoid Switzerland due to class imbalance
- Separate screening vs diagnostic models to prevent data leakage

### Clinical Considerations
- Feature set represents initial screening (primary care visit)
- Model provides risk probability, not diagnosis
- Requires clinical judgment for interpretation
- Research/educational use only

## Deliverables

### Code Modules
1. `data_loader.py` - Dataset loading and validation
2. `preprocessing.py` - Feature preprocessing pipeline
3. `models.py` - Model implementations
4. `evaluation.py` - Comprehensive evaluation metrics
5. `explainability.py` - SHAP and feature importance analysis
6. `external_validation.py` - External cohort validation
7. `train.py` - Main training script
8. `tests/test_input_validation.py` - Input validation tests

### Documentation
1. `dataset_verification_report.md` - Dataset quality assessment
2. `feature_selection_strategy.md` - Feature selection rationale
3. `model_card.md` - Model documentation
4. `training_results.md` - Training configuration

## Next Steps

### Immediate
1. Execute training pipeline with actual data
2. Generate model performance reports
3. Run SHAP explainability analysis
4. Perform external validation

### Frontend Integration
1. Build React dashboard with risk visualization
2. Implement 3D heart visualization (Blender MCP)
3. Create explainable AI results display
4. Develop risk factor scenario explorer

### Backend Integration
1. Build FastAPI prediction endpoint
2. Implement input validation
3. Add model versioning
4. Create API documentation

## Critical Warnings

1. **No Clinical Validation**: Model not validated for clinical use
2. **Historical Data**: Dataset from 1980s, may not reflect modern populations
3. **Data Leakage Risk**: Careful feature selection required
4. **Research Use Only**: Not for diagnostic decision-making

## References

- UCI Heart Disease Dataset
- Detrano et al. (1989). American Journal of Cardiology
- Model Card: Google ML Model Transparency
